AlphAIAlphAI — Financial news for AI agents
finance.yahoo.comOCT 271 min read$CNC

Centene (NYSE:CNC) delivers strong Q3 2026 numbers, full-year outlook slightly exceeds expectations

Centene (CNC) reported Q3 2026 revenue of $50.65B, beating estimates by 8.2%, and adjusted EPS of $0.58, significantly above expectations. The company raised full-year revenue guidance to $198.5B and adjusted EPS guidance to $5.20. Operating margin improved to -0.6%, while free cash flow declined to -$3.86B. Customer count decreased slightly to 25.7M.

Original reporting
finance.yahoo.com
Published Oct 27, 2026, 10:19 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 27, 2026, 11:50 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Centene (NYSE:CNC) delivers strong Q3 2026 numbers, full-year outlook slightly exceeds expectations — source image
Source · finance.yahoo.com
Decision brief

The 30-second read

$CNCBullishHigh
01

Why it matters

The earnings surprise and guidance lift are likely to drive a short‑term price increase, though margin and cash flow concerns could limit upside.

02

Market read

Centene's earnings beat and guidance raise are material for traders focusing on healthcare stocks and the broader market.

03

What to watch

Margin compression and negative free cash flow may temper enthusiasm.

Relevance 9/10Novelty 9/10Timing: today

Background

Centene (NYSE:CNC) posted Q3 2026 results with revenue of $50.65 B versus $46.81 B consensus and adjusted EPS of $0.58 versus $0.10 consensus, and raised its full‑year guidance.

Company-level read

Ticker impact

$CNCBullishHigh confidence
Context

Centene reported Q3 2026 results beating revenue and EPS estimates and raised full-year guidance.

Expected impact

upward pressure as the market prices in the earnings beat and higher guidance

Evidence & confidence

Revenue and EPS both beat consensus, and full-year guidance was increased, which typically drives buying interest.

Market effects

Sector

Health insurance sector may see broader optimism from Centene's beat.

Regional

U.S. healthcare stocks could experience modest gains.

Global

Limited to U.S. markets; no direct global impact.

Counterpoint

What could challenge this read

If the beat is already priced in, the stock could face short-term profit taking.

Key entities

  • company
    Centene

    U.S. health insurer reporting Q3 2026 earnings.

Read at source← All news

StoryCentene posts Q3 2026 loss but lifts 2026 EPS guidance

Also covered by

4 outlets

Related articles

OCT 27
$CNCMedAI 8/10

Centene Corp (CNC) (Q3 2026) Earnings Call Highlights: Raised Guidance and Medicare

Centene Corp (CNC) reported Q3 2026 earnings, raising guidance. Medicaid membership is expected to decline 8-9% YoY by 2026 end, with further attrition in 2027. Medicare Advantage membership may drop YoY in 2027. PDP pretax margin is forecasted to reset lower in 2027, initially at 2-3%. CEO Sarah London addressed market contraction expectations and cost-saving measures during the earnings call.

finance.yahoo.com3 min
OCT 27
$CNCMedAI 8/10

What Centene (CNC) Said on Its Q3 Earnings Call

Centene (CNC) reported Q3 earnings, highlighting strong Medicare segment performance with a 93.8% HBR. The company raised its 2026 pre-tax margin forecast for PDP to mid-to-high 3% and expects Medicare Advantage break-even in 2026. Marketplace margins are improving, with a full-year 2026 pre-tax margin expected at the top of the 4.5%-5% range. Centene reduced debt to $15.0B and expects adjusted EPS growth in 2027.

finance.yahoo.com2 min
OCT 27
$CNCHighAI 8/10

Centene (CNC) Q3 2026 Earnings Call Transcript

Centene (CNC) reported Q3 2026 earnings, highlighting a Medicaid HBR of 93.6, up 30 basis points from Q2. The company expects full-year Medicaid HBR of 93.5. Medicaid membership was in line with expectations, with a projected 8-9% year-end decline. Medicare Advantage and standalone Part D performed well, with Medicare Advantage on track for 2026 breakeven. Marketplace business is expected to produce a full-year pretax margin at the top of the 4.5% to 5.0% range.

finance.yahoo.com3 min
OCT 27
$CNCMed

Centene Corporation Q3 2026 Earnings Call Summary

Centene Corporation reported Q3 2026 earnings, highlighting Medicare Advantage breakeven, Medicaid stability, and Marketplace margin recovery. The company reduced debt to $15.0 billion and expects 2027 adjusted EPS growth. Management plans to exit less profitable areas and optimize costs. Medicaid membership is declining, and Marketplace enrollment may contract in 2027. Non-recurring benefits added $0.50 per share in 2026.

finance.yahoo.com3 min
OCT 27
$CNCMed

Centene progresses on profit recovery, drops 6,000 employees

Centene reported Q3 revenue of $50.6B, up 2% YoY, and narrowed losses to $71M. The company raised its 2026 earnings outlook due to Medicare Advantage cost reductions, now expecting to break even in the segment. Centene also announced layoffs and voluntary separations, reducing its workforce by 6,000 employees, which is expected to improve margins in 2027. The company's medical loss ratio was 92.7%, slightly better than expected.

finance.yahoo.com3 min